Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1H4 | Q96RI1 | 7/20 | 0.57 |
| ▸ | ABCB1 | P08183 | 3/20 | 0.46 |
| ▸ | ABCG2 | Q9UNQ0 | 3/20 | 0.46 |
| ▸ | CDK4 | P11802 | 3/20 | 0.46 |
| ▸ | CCND1 | P24385 | 3/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL687830 | 0.96 | NR1H4 (0.56) | NR1H4ABCB1ABCG2CDK4CCND1 | |
| SCHEMBL687653 | 0.96 | NR1H4 (0.56) | NR1H4ABCB1ABCG2CDK4CCND1 | |
| SCHEMBL688141 | 0.87 | NR1H4 (0.57) | NR1H4ABCB1ABCG2CDK4CCND1 | |
| SCHEMBL275227 | 0.84 | NR1H4 (0.65) | NR1H4ABCB1ABCG2CDK4CCND1 | |
| SCHEMBL689326 | 0.84 | NR1H4 (0.63) | NR1H4ABCB1ABCG2CDK4CCND1 | |
| SCHEMBL689085 | 0.82 | NR1H4 (0.61) | NR1H4ABCB1ABCG2CDK4CCND1 | |
| SCHEMBL275327 | 0.81 | NR1H4 (0.63) | NR1H4ABCB1ABCG2CDK4CCND1 | |
| SCHEMBL275053 | 0.81 | NR1H4 (0.63) | NR1H4ABCB1ABCG2CDK4CCND1 | |
| SCHEMBL273104 | 0.80 | NR1H4 (0.62) | NR1H4ABCB1ABCG2CDK4CCND1 | |
| SCHEMBL688953 | 0.80 | NR1H4 (0.41) | NR1H4ABCB1ABCG2CDK4CCND1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1532153-B1 | AZEPINOINDOLE AND PYRIDOINDOLE DERIVATIVES AS PHARMACEUTICAL AGENTS | X CEPTOR THERAPEUTICS INC (US) | 2012-02-29 | — | — | EP | claimed |